Carcinogenesis Advance Access originally published online on March 28, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carcinogenesis, Vol. 24, No. 5, 883-889,
May 2003
© 2003 Oxford University Press
MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION |
DNA damage and breast cancer risk
1 Department of Cancer Biology, Wake Forest University Health Sciences, Medical Center Blvd., Winston-Salem, NC 27157, USA
2 Comprehensive Cancer Center, Wake Forest University Health Sciences, Winston-Salem, NC, USA
3 Department of Public Health Sciences, Wake Forest University Health Sciences, Winston-Salem, NC, USA
4 To whom correspondence should be addressed Email: jenhu{at}wfubmc.edu
To evaluate whether deficient DNA repair contributes to elevated DNA damage and breast carcinogenesis, we used the comet assay (single-cell alkaline gel electrophoresis) to measure the levels of DNA damage in peripheral lymphocytes from 70 breast cancer cases and 70 controls. DNA damage, measured as the comet tail moment, was not influenced by age, family history (FH), age at menarche, age at first birth or parity. The results showed that cancer cases had significantly higher DNA damage compared with controls; the comet tail moments (mean ± SD) for cases and controls were: 10.78 ± 3.63 and 6.86 ± 2.76 (P < 0.001) for DNA damage at baseline (DB), 21.24 ± 4.88 and 14.97 ± 4.18 (P < 0.001) for DNA damage after exposure to 6 Gy of ionizing radiation (DIR), and 14.76 ± 5.35 and 9.75 ± 3.35 (P < 0.001) for DNA damage remaining after 10 min repair following exposure to 6 Gy of IR (DRP), respectively. Body mass index (BMI) affected DNA damage differently for cases and controls. Damage decreased with increasing BMI for controls, while damage increased with increasing BMI for cases. Above-median DNA damage was significantly associated with breast cancer risk; the age-adjusted odds ratio (OR) = 13.44 [95% confidence interval (CI) = 5.97–30.24] for DB, 13.65 (6.07–30.71) for DIR and 6.54 (3.11–13.79) for DRP, respectively. This association was stronger in women with above-median BMI. Our results, although based on a relatively small group of subjects, indicate that elevated DNA damage is significantly associated with breast cancer risk and warrant larger studies to further define the molecular mechanisms of DNA damage/repair in breast cancer susceptibility.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. J. McKenna, S. R. McKeown, and V. J. McKelvey-Martin Potential use of the comet assay in the clinical management of cancer Mutagenesis, May 1, 2008; 23(3): 183 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Bhatti, A. J. Sigurdson, C. B. Thomas, A. Iwan, B. H. Alexander, D. Kampa, L. Bowen, M. M. Doody, and I. M. Jones No Evidence for Differences in DNA Damage Assessed before and after a Cancer Diagnosis Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 990 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Waters, S. Shen, H. Xu, S. S. Kengeri, D. M. Cooley, E. C. Chiang, Y. Chen, D. Schlittler, C. Oteham, G. F. Combs Jr., et al. Noninvasive Prediction of Prostatic DNA Damage by Oxidative Stress Challenge of Peripheral Blood Lymphocytes Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1906 - 1910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Thyagarajan, K. E. Anderson, C. J. Lessard, G. Veltri, D. R. Jacobs, A. R. Folsom, and M. D. Gross Alkaline unwinding flow cytometry assay to measure nucleotide excision repair Mutagenesis, March 1, 2007; 22(2): 147 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Lockett, M.C. Hall, P. E. Clark, S.-C. Chuang, B. Robinson, H.-Y. Lin, L.J. Su, and J. J. Hu DNA damage levels in prostate cancer cases and controls Carcinogenesis, June 1, 2006; 27(6): 1187 - 1193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhao, G. Aldini, E. J Johnson, H. Rasmussen, K. Kraemer, H. Woolf, N. Musaeus, N. I Krinsky, R. M Russell, and K.-J. Yeum Modification of lymphocyte DNA damage by carotenoid supplementation in postmenopausal women Am. J. Clinical Nutrition, January 1, 2006; 83(1): 163 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Millikan, J. S. Player, A. R. deCotret, C.-K. Tse, and T. Keku Polymorphisms in DNA Repair Genes, Medical Exposure to Ionizing Radiation, and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2326 - 2334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Trenz, P. Schutz, and G. Speit Radiosensitivity of lymphoblastoid cell lines with a heterozygous BRCA1 mutation is not detected by the comet assay and pulsed field gel electrophoresis Mutagenesis, March 1, 2005; 20(2): 131 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. O. Kennedy, M. Agrawal, J. Shen, M. B. Terry, F. F. Zhang, R. T. Senie, G. Motykiewicz, and R. M. Santella DNA Repair Capacity of Lymphoblastoid Cell Lines From Sisters Discordant for Breast Cancer J Natl Cancer Inst, January 19, 2005; 97(2): 127 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Blumberg Use of Biomarkers of Oxidative Stress in Research Studies J. Nutr., November 1, 2004; 134(11): 3188S - 3189S. [Full Text] [PDF]
|
|
|
|
|
|
M. S.P. Ladeira, M. A.M. Rodrigues, D. M.F. Salvadori, D. M.M. Queiroz, and D. V. Freire-Maia DNA Damage in Patients Infected by Helicobacter pylori Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 631 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Caporaso The Molecular Epidemiology of Oxidative Damage to DNA and Cancer J Natl Cancer Inst, September 3, 2003; 95(17): 1263 - 1265. [Full Text] [PDF]
|
|